Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 2
2004 6
2005 7
2006 9
2007 8
2008 5
2009 4
2010 11
2011 6
2012 7
2013 6
2014 3
2015 12
2016 8
2017 9
2018 19
2019 10
2020 15
2021 7
2022 9
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

154 results

Results by year

Filters applied: . Clear all
Page 1
Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial.
Khanna D, Lin CJF, Furst DE, Goldin J, Kim G, Kuwana M, Allanore Y, Matucci-Cerinic M, Distler O, Shima Y, van Laar JM, Spotswood H, Wagner B, Siegel J, Jahreis A, Denton CP; focuSSced investigators. Khanna D, et al. Lancet Respir Med. 2020 Oct;8(10):963-974. doi: 10.1016/S2213-2600(20)30318-0. Epub 2020 Aug 28. Lancet Respir Med. 2020. PMID: 32866440 Clinical Trial.
[Early reumatoid arthritis].
Kolarz K, Targońska-Stępniak B, Majdan M. Kolarz K, et al. Among authors: majdan m. Wiad Lek. 2018;71(5):1061-1065. Wiad Lek. 2018. PMID: 30176641 Review. Polish.
Haematological abnormalities in systemic sclerosis.
Wielosz E, Majdan M. Wielosz E, et al. Among authors: majdan m. Reumatologia. 2020;58(3):162-166. doi: 10.5114/reum.2020.96655. Epub 2020 Jun 29. Reumatologia. 2020. PMID: 32684649 Free PMC article. Review.
Arterial hypertension in systemic sclerosis.
Wielosz E, Dryglewska M, Górak A, Łyś E, Majdan M. Wielosz E, et al. Among authors: majdan m. Postepy Dermatol Alergol. 2022 Oct;39(5):865-871. doi: 10.5114/ada.2022.120881. Epub 2022 Nov 9. Postepy Dermatol Alergol. 2022. PMID: 36457666 Free PMC article.
Phase 2 Trial of Iberdomide in Systemic Lupus Erythematosus.
Merrill JT, Werth VP, Furie R, van Vollenhoven R, Dörner T, Petronijevic M, Velasco J, Majdan M, Irazoque-Palazuelos F, Weiswasser M, Korish S, Ye Y, Gaudy A, Schafer PH, Liu Z, Agafonova N, Delev N. Merrill JT, et al. Among authors: majdan m. N Engl J Med. 2022 Mar 17;386(11):1034-1045. doi: 10.1056/NEJMoa2106535. N Engl J Med. 2022. PMID: 35294813 Clinical Trial.
Biological impact of iberdomide in patients with active systemic lupus erythematosus.
Lipsky PE, Vollenhoven RV, Dörner T, Werth VP, Merrill JT, Furie R, Petronijevic M, Velasco Zamora B, Majdan M, Irazoque-Palazuelos F, Terbrueggen R, Delev N, Weiswasser M, Korish S, Stern M, Hersey S, Ye Y, Gaudy A, Liu Z, Gagnon R, Tang S, Schafer PH. Lipsky PE, et al. Among authors: majdan m. Ann Rheum Dis. 2022 Apr 27;81(8):1136-42. doi: 10.1136/annrheumdis-2022-222212. Online ahead of print. Ann Rheum Dis. 2022. PMID: 35477518 Free PMC article.
154 results